We are live on ! Find out more
TMBR

Timber Pharmaceuticals, Inc.
TMBR

Delisted

TMBR was delisted on the 28th of November, 2023.

Back to rankings

18 hedge funds and large institutions have $7.8M invested in Timber Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

6% more funds holding

Funds holding: 17 → 18 (+1)

40% less capital invested

Capital invested by funds: $13.1M → $7.8M (-$5.29M)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$87.3K
2
VF
Virtu Financial
New York
+$51.4K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.3K
4
Citadel Advisors
Citadel Advisors
Florida
+$5.14K
5
TSS
Two Sigma Securities
New York
+$5.14K

Top Sellers

Rank Fund Capital Flow
1
MC
Moors & Cabot
Massachusetts
-$19K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$5.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Vivo Capital
California
$4.03M – – –
Franklin Resources
2
Franklin Resources
California
$2.79M +$87.3K +17 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$560K +$5.14K +1 +0.8%
BBA
4
Baker Bros. Advisors
New York
$171K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$92K – – –
VF
6
Virtu Financial
New York
$43K +$51.4K +10 New
Northern Trust
7
Northern Trust
Illinois
$26K – – –
FWSM
8
First Wilshire Securities Management
California
$17K – – –
LPL Financial
9
LPL Financial
California
$11K – – –
GC
10
Guggenheim Capital
Illinois
$9K – – –
OC
11
Oppenheimer & Co
New York
$9K – – –
TSS
12
Two Sigma Securities
New York
$9K +$5.14K +1 +100%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$9K +$10.3K +2 New
Citadel Advisors
14
Citadel Advisors
Florida
$8K +$5.14K +1 +100%
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$6K – – –
Bank of New York Mellon
16
Bank of New York Mellon
New York
$5K -$5.14K -1 -50%
CB
17
Commerce Bank
Missouri
$3K – – –
UBS Group
18
UBS Group
Switzerland
$3K +$5.14K +1 New
BlackRock
19
BlackRock
New York
$1K – – –
MC
20
Moors & Cabot
Massachusetts
– -$19K -3 Closed

TMBR Hedge Fund Activity: Q3 2017 in Review

18 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q3 2017, worth a combined $7.8M — down 40% from $13.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TMBR positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Franklin Resources, adding an estimated $87.3K. The largest seller was Moors & Cabot, exiting entirely with an estimated $19K sold.

  • 18 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q3 2017, up from 17 in Q2 2017.
  • Funds reported $7.8M of Timber Pharmaceuticals, Inc. stock for Q3 2017, down 40% quarter-over-quarter.
  • 3 funds opened new Timber Pharmaceuticals, Inc. positions in Q3 2017 and 1 closed out, a net change of +2 holders.
  • The largest Timber Pharmaceuticals, Inc. buyer in Q3 2017 was Franklin Resources, an estimated $87.3K added.
  • The largest Timber Pharmaceuticals, Inc. seller in Q3 2017 was Moors & Cabot, an estimated $19K sold.

Based on aggregated 13F filings for Q3 2017.